These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 1462022

  • 1. Chronic persistent cough: use of ipratropium bromide in undiagnosed cases following upper respiratory tract infection.
    Holmes PW, Barter CE, Pierce RJ.
    Respir Med; 1992 Sep; 86(5):425-9. PubMed ID: 1462022
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhaled corticosteroid for persistent cough following upper respiratory tract infection.
    Pornsuriyasak P, Charoenpan P, Vongvivat K, Thakkinstian A.
    Respirology; 2005 Sep; 10(4):520-4. PubMed ID: 16135178
    [Abstract] [Full Text] [Related]

  • 7. For COPD a combination of ipratropium bromide and albuterol sulfate is more effective than albuterol base.
    Campbell S.
    Arch Intern Med; 1999 Jan 25; 159(2):156-60. PubMed ID: 9927098
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Protective effects of inhaled ipratropium bromide on bronchoconstriction induced by adenosine and methacholine in asthma.
    Crimi N, Palermo F, Oliveri R, Polosa R, Settinieri I, Mistretta A.
    Eur Respir J; 1992 May 25; 5(5):560-5. PubMed ID: 1535321
    [Abstract] [Full Text] [Related]

  • 10. Is oral theophylline effective in combination with both inhaled anticholinergic agent and inhaled beta 2-agonist in the treatment of stable COPD?
    Nishimura K, Koyama H, Ikeda A, Izumi T.
    Chest; 1993 Jul 25; 104(1):179-84. PubMed ID: 8325065
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Airways responses to ipratropium bromide do not vary with time in asthmatic subjects. Studies of interindividual and intraindividual variation of bronchodilatation and protection against histamine-induced bronchoconstriction.
    Ihre E, Larsson K.
    Chest; 1990 Jan 25; 97(1):46-51. PubMed ID: 2136826
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial. COMBIVENT Inhalation Aerosol Study Group.
    Chest; 1994 May 25; 105(5):1411-9. PubMed ID: 8181328
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The acute effect of ipratropium bromide bronchodilator therapy on cough clearance in COPD.
    Bennett WD, Chapman WF, Mascarella JM.
    Chest; 1993 Feb 25; 103(2):488-95. PubMed ID: 8432142
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDI.
    Zuwallack R, De Salvo MC, Kaelin T, Bateman ED, Park CS, Abrahams R, Fakih F, Sachs P, Pudi K, Zhao Y, Wood CC, Combivent Respimat Inhaler Study Group.
    Respir Med; 2010 Aug 25; 104(8):1179-88. PubMed ID: 20172704
    [Abstract] [Full Text] [Related]

  • 18. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
    Jarvis B, Markham A.
    Drugs Aging; 2001 Aug 25; 18(6):441-72. PubMed ID: 11419918
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone.
    Ikeda A, Nishimura K, Koyama H, Izumi T.
    Chest; 1995 Feb 25; 107(2):401-5. PubMed ID: 7842768
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.